Teyi Pharmaceutical (002728): Leading brands of traditional Chinese medicine are reviving under a two-pronged approach of channels and new products
Teyi Pharmaceutical (002728): Strong growth in cough medicine, actively promoting changes in marketing organization
Teyi Pharmaceutical (002728) Investment Value Analysis Report: The volume and price of exclusive specialty cough tablets have broad prospects for rising
Research Report Nuggets | Huaxin Securities: Teyi Pharmaceutical's demand for cough relief tablets has surged, vigorously developing high-end medical and aesthetic varieties, giving them a “buy” rating
特一药业(002728):止咳宝片销量增长 销售体系升级收效明显
TEI PHARMACEUTICAL (002728): Significant increase in performance and sustainable expectations for the “1+N” product tier
Te Yi Pharmaceutical (002728): Net profit growth exceeds expectations after deducting non-return to the mother. Featured brands are worth looking forward to
Te Yi Pharmaceutical (002728): Building a “1+N” development matrix around the characteristics of traditional Chinese medicine for cough suppressants
[CSC FINANCIAL CO.,LTD] Taicheng Pharmaceutical: general pharmaceutical enterprises with regional characteristics
[northeast Securities] Taicheng Pharmaceutical New share pricing report: general Pharmaceutical Enterprises with South China characteristics
[Shenyin Wanguo Securities] Taicheng Pharmaceutical: Xu family holding, income and net profit grow steadily
[Haitong] Taicheng Pharmaceutical: an excellent general pharmaceutical enterprise with Lingnan characteristics
[Dongxing Securities] Taicheng Pharmaceutical: high-quality general pharmaceutical enterprises in South China
[Qilu Securities] Taicheng Pharmaceutical: a general pharmaceutical enterprise in the transformation of product structure
[Anxin Securities] Taicheng Pharmaceutical: a general pharmaceutical enterprise with excellent varieties
[Guotai Junan Securities] Taicheng Pharmaceutical-IPO IPO inquiry analysis report: Lingnan characteristic proprietary Chinese medicine enterprises
No Data
No Data